Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for SENSIPAR
- Novel Combination Therapy for Osteoporosis in Men
- Treatment of Primary Hyperparathyroidism With Denosumab and Cinacalcet.
- Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary Hyperparathyroidism
- Cincalcet and Vascular Arterial Stiffness Among Peritoneal Dialysis Patients With Secondary Hyperparathyroidism
- Cinacalcet Hydrochloride in Treating Men With Recurrent Prostate Cancer
- Using Cinacalcet to Treat the Hypophosphatemia of Early Kidney Transplant
- Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose Vitamin D
- Efficacy and Safety Study of Cinacalcet for the Treatment of Hypercalcemia in Patients With Primary Hyperparathyroidism Unable to Undergo Parathyroidectomy
- Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients
- Calcimimetics in Hypophosphatemic Rickets
- A Study of Cinacalcet to Improve Achievement of National Kidney Foundation Kidney Disease Outcomes Quality Initiative (K/DOQI) Targets in Patients With End Stage Renal Disease (ESRD)
- Post Transplant Study
- E.V.O.L.V.E. Trialâ„¢: EValuation Of Cinacalcet Hydrochloride (HCl) Therapy to Lower CardioVascular Events
- Effect of Cinacalcet on Parathyroid Hormone Secretion in Children and Adolescents With Hypophosphatemic Rickets
- A Multi-Center, Observational Registry of Subjects With Secondary Hyperparathyroidism (HPT) and Chronic Kidney Disease (CKD)
- ACHIEVE: Optimizing the Treatment of Secondary Hyperparathyroidism
- START: Sensipar Treatment Algorithm to Reach K/DOQI Targets in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism
Clinical trials list
click for details